Subject to TSX Venture Exchange (“ TSXV ”) approval, NurExone has engaged Russo Partners LLC, a New York–based strategic communications firm, (“ Russo ”) for an initial consulting project for up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback